(Q38267240)

1 September 2017

1 reference

title

Potential mechanisms for cell-based gene therapy to treat HIV/AIDS. (English)

1 reference

1 September 2017

0 references

0 references

Elena Herrera-Carrillo

series ordinal

1

object named as

Elena Herrera-Carrillo

1 reference

1 September 2017

2

Ben Berkhout

1 reference

1 September 2017

language of work or name

English

0 references

publication date

12 November 2014

1 reference

Expert Opinion on Therapeutic Targets

1 September 2017

published in

1 reference

1 September 2017

volume

19

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

245-263

1 reference

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

CD4(+) T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory act

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Gene therapy. Intracellular immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Selective translational repression of HIV-1 RNA by Sam68DeltaC occurs by altering PABP1 binding to unspliced viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV-1 proprotein processing as a target for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of replication of HIV-1 at both early and late stages of the viral life cycle by single-chain antibody against viral integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-1 by fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with hu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Primitive hematopoietic cells resist HIV-1 infection via p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

The mechanism of human nonhomologous DNA end joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Zinc finger endonuclease targeting PSIP1 inhibits HIV-1 integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Hematopoietic-stem-cell-based gene therapy for HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Xanthomonas AvrBs3 family-type III effectors: discovery and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

TALENs: a widely applicable technology for targeted genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Unravelling the structural and mechanistic basis of CRISPR-Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV-1 proviral DNA excision using an evolved recombinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Gene therapy strategies: can we eradicate HIV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Use of modified U1 snRNAs to inhibit HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Design of modified U1i molecules against HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A nucleolar TAR decoy inhibitor of HIV-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

RNA-mediated inhibition of HIV in a gene therapy setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Gene transfer in humans using a conditionally replicating lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Dicer-independent processing of short hairpin RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Towards improved shRNA and miRNA reagents as inhibitors of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Silencing of HIV-1 with RNA interference: a multiple shRNA approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

RNA polymerase III can drive polycistronic expression of functional interfering RNAs designed to resemble microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Combinatorial RNAi against HIV-1 using extended short hairpin RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Design of extended short hairpin RNAs for HIV-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Directed HIV-1 evolution of protease inhibitor resistance by second-generation short hairpin RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A systematic analysis of the effect of target RNA structure on RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

SHAPE-directed discovery of potent shRNA inhibitors of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Preclinical in vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Autologous hematopoietic cell transplantation in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Towards an HIV cure: a global scientific strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

The many lives of CTIP2: from AIDS to cancer and cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Achieving a cure for HIV infection: do we have reasons to be optimistic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Cell-associated HIV RNA: a dynamic biomarker of viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Gene therapy-based treatment for HIV-positive patients with malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Induction of an interferon response by RNAi vectors in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.980236

10.1517/14728222.2014.980236

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference